文献速递血栓与止血

825例儿童非重型血友病患者出血表型与凝血因子水平的关系:来自PedNet队列的数据

Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort.
PubMed 文献 · J Thromb Haemost · 2024-06-10

国际PedNet队列纳入2000年后出生的825例未接受预防治疗的非重型血友病患儿,分析内源性FVIII/FIX活性与年化出血率、年化关节出血率及出血发生年龄的关系。结果显示FVIII/FIX活性>5%可显著降低关节出血率,FVIII>15%和FIX>10%足以在该儿科队列中实现零出血目标。

要点

  • 非重型血友病患儿内源性FVIII/FIX活性>5%是显著降低关节出血率的阈值。
  • FVIII活性>15%和FIX活性>10%足以在该儿科队列中实现零出血目标。
  • 内源性FVIII从1%-2%升至21%-25%时,出血发生年龄中位数从1.4岁升至14.2岁。

核心结论

  • 内源性凝血因子活性>5%被确定为显著降低关节出血率的阈值。
  • FVIII水平>15%和FIX水平>10%足以在该儿科队列中实现零出血目标。

研究设计与样本

  • 国际PedNet队列研究,纳入2000年后出生的非重型血友病A和B患儿,凝血因子VIII/FIX活性1%-25%,未接受预防治疗。
  • 共纳入825例患儿,其中40%为中型血友病,87%为血友病A,每名患儿中位随访7.4年。

主要发现

  • 内源性FVIII从1%-2%升至21%-25%时,出血发生年龄中位数从1.4岁升至14.2岁,年化出血率从1.6/年降至0.1/年,年化关节出血率从0.5/年降至0.0/年。
  • 内源性FIX从1%-2%升至16%-25%时,出血发生年龄中位数从1.7岁升至6.1岁,年化出血率从0.5/年降至0.1/年,年化关节出血率从0.1/年降至0.0/年。
  • 年化关节出血率与凝血因子水平的负相关在血友病A和血友病B中均在凝血因子水平至6%时最为明显。

关键数值与推荐

  • 内源性FVIII/FIX活性分组为1%-2%、3%-5%、6%-10%、11%-15%、16%-20%和21%-25%。
  • 年化出血率和年化关节出血率采用负二项回归建模比较,出血发生采用Kaplan-Meier生存曲线分析。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Information on bleeding phenotype in nonsevere hemophilia may be used to determine target factor levels for prophylaxis or gene therapy in severe hemophilia. OBJECTIVES: To assess the association between endogenous factor level and bleeding phenotype in children with nonsevere (factor [F]VIII/FIX activity 1%-25%) hemophilia A (HA) and B without prophylaxis. METHODS: Data on annualized bleeding rate (ABR), annualized joint bleeding rate (AJBR), and onset of bleeding were extracted from the international PedNet cohort including children born since 2000. Mean ABR and AJBR were modeled and compared according to FVIII/FIX endogenous activity (1%-2%, 3%-5%, 6%-10%, 11%-15%, 16%-20%, and 21%-25%) using negative binomial regression. Onset of bleeding was analyzed using Kaplan-Meier survival curves. RESULTS: Eight hundred twenty-five children (40% with moderate hemophilia; 87% with HA) with median follow-up of 7.4 years/child were included. The median age at onset of bleeding and median bleeding rates changed with increasing endogenous activity. From endogenous FVIII 1% to 2% to 21% to 25%, the age at onset of bleeding changed from a median of 1.4 to 14.2 years, ABR from 1.6 to 0.1/y, and AJBR from 0.5 to 0.0/y. From endogenous FIX 1% to 2% to 16% to 25%, the onset of bleeding changed from a median of 1.7 to 6.1 years, ABR from 0.5 to 0.1/y, and AJBR from 0.1 to 0.0/y. The negative correlation between AJBR and factor level was most strongly pronounced up to a factor level of 6% in HA and hemophilia B. CONCLUSION: Endogenous factor activity of >5% was identified as a threshold to significantly lower joint bleeding rate, while FVIII levels >15% and FIX levels >10% were sufficient to achieve the goal of 0 bleeds in this pediatric cohort.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. de Kovel MS, Escuriola-Ettingshausen C, Königs C, et al. Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort. J Thromb Haemost. 2024. PMID: 38866249. doi:10.1016/j.jtha.2024.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。